Version 5.4
Bos taurus Protein: IFI30
Summary
InnateDB Protein IDBP-694150.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol IFI30
Protein Name gamma-interferon-inducible lysosomal thiol reductase
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000045061
InnateDB Gene IDBG-641754 (IFI30)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0003723 RNA binding
GO:0016667 oxidoreductase activity, acting on a sulfur group of donors
Biological Process
GO:0019886 antigen processing and presentation of exogenous peptide antigen via MHC class II
GO:0042590 antigen processing and presentation of exogenous peptide antigen via MHC class I
GO:0048147 negative regulation of fibroblast proliferation
GO:0050821 protein stabilization
Cellular Component
GO:0005737 cytoplasm
GO:0005764 lysosome
GO:0005886 plasma membrane
GO:0030054 cell junction
GO:0043231 intracellular membrane-bounded organelle
Protein Structure and Domains
PDB ID
InterPro IPR004911 Gamma interferon inducible lysosomal thiol reductase GILT
IPR009019 K homology domain, prokaryotic type
PFAM PF03227
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL F1MAU3
UniProt Splice Variant
Entrez Gene 615930
UniGene Bt.1548
RefSeq NP_001094721
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02019062 DAAA02019063
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca